VAN ANDEL RESEARCH INSTITUTE: Form 990, tax year 2011

View the entire original 990 at ProPublica ↗

Organization
VAN ANDEL RESEARCH INSTITUTE (EIN 52-2000823)
Tax period
2011-12-01 to 2012-11-30
Filed
2013-10-11
IRS object ID
201332849349300018
Schema version
2011v1.5
Source
Download XML · Original 990 at ProPublica

Every field in the e-filed return. Faint text is the IRS element name, for citing.

Return header ReturnHeader

FieldValueIRS element (for citing)
Timestamp2013-10-11T11:04:10-05:00Timestamp
Tax Period End Date2012-11-30TaxPeriodEndDate

Preparer Firm PreparerFirm

FieldValueIRS element (for citing)
EIN861065772EIN

Preparer Firm Business Name PreparerFirmBusinessName

FieldValueIRS element (for citing)
Business Name Line1DELOITTE TAX LLPBusinessNameLine1

Preparer Firm US Address PreparerFirmUSAddress

FieldValueIRS element (for citing)
Address Line1200 RENAISSANCE CENTER STE 3900AddressLine1
CityDETROITCity
StateMIState
ZIP Code48243ZIPCode
FieldValueIRS element (for citing)
Return Type990ReturnType
Tax Period Begin Date2011-12-01TaxPeriodBeginDate

Filer Filer

FieldValueIRS element (for citing)
EIN522000823EIN

Name Name

FieldValueIRS element (for citing)
Business Name Line1VAN ANDEL RESEARCH INSTITUTEBusinessNameLine1
FieldValueIRS element (for citing)
Name ControlVANANameControl
Phone6162345000Phone

US Address USAddress

FieldValueIRS element (for citing)
Address Line1333 BOSTWICK AVENUE NEAddressLine1
CityGRAND RAPIDSCity
StateMIState
ZIP Code49503ZIPCode

Officer Officer

FieldValueIRS element (for citing)
NameTIMOTHY J MYERSName
TitleCFOTitle
Phone6162345368Phone
Date Signed2013-10-11DateSigned
Authorize Third Party1AuthorizeThirdParty

Preparer Preparer

FieldValueIRS element (for citing)
NameLORI BOYCEName
PTINP00121981PTIN
Phone3133963000Phone
FieldValueIRS element (for citing)
Tax Year2011TaxYear
Build TS2016-02-25 16:41:14ZBuildTS

Form 990 IRS990

FieldValueIRS element (for citing)
Name Of Principal Officer PersonTIMOTHY J MYERSNameOfPrincipalOfficerPerson

Address Principal Officer US AddressPrincipalOfficerUS

FieldValueIRS element (for citing)
Address Line1333 BOSTWICK AVENUE NEAddressLine1
CityGRAND RAPIDSCity
StateMIState
ZIP Code49503ZIPCode
FieldValueIRS element (for citing)
Gross Receipts72051806GrossReceipts
Group Return For Affiliates0GroupReturnForAffiliates
Organization501c3XOrganization501c3
Web SiteWWW.VAI.ORGWebSite
Type Of Organization TrustXTypeOfOrganizationTrust
Year Formation1996YearFormation
State Legal DomicileMIStateLegalDomicile
Activity Or Mission DescriptionMEDICAL RESEARCH ORGANIZATIONActivityOrMissionDescription
Nbr Voting Members Governing Body5NbrVotingMembersGoverningBody
Nbr Independent Voting Members3NbrIndependentVotingMembers
Total Nbr Employees367TotalNbrEmployees
Total Nbr Volunteers0TotalNbrVolunteers
Total Gross UBI897673TotalGrossUBI
Net Unrelated Business Txbl Income80719NetUnrelatedBusinessTxblIncome
Contributions Grants Prior Year57012820ContributionsGrantsPriorYear
Contributions Grants Current Year57997024ContributionsGrantsCurrentYear
Program Service Revenue Prior Year1522584ProgramServiceRevenuePriorYear
Program Service Revenue CY1242591ProgramServiceRevenueCY
Investment Income Prior Year819423InvestmentIncomePriorYear
Investment Income Current Year333140InvestmentIncomeCurrentYear
Other Revenue Prior Year4334013OtherRevenuePriorYear
Other Revenue Current Year10471022OtherRevenueCurrentYear
Total Revenue Prior Year63688840TotalRevenuePriorYear
Total Revenue Current Year70043777TotalRevenueCurrentYear
Grants And Similar Amnts Prior Year340825GrantsAndSimilarAmntsPriorYear
Grants And Similar Amnts CY341390GrantsAndSimilarAmntsCY
Benefits Paid To Members Prior Year0BenefitsPaidToMembersPriorYear
Benefits Paid To Members CY0BenefitsPaidToMembersCY
Salaries Etc Prior Year26065382SalariesEtcPriorYear
Salaries Etc Current Year27658068SalariesEtcCurrentYear
Total Prof Fundrsng Exp Prior Year0TotalProfFundrsngExpPriorYear
Total Prof Fundrsng Exp CY0TotalProfFundrsngExpCY
Total Fundrsng Exp Current Year412173TotalFundrsngExpCurrentYear
Other Expense Prior Year39147197OtherExpensePriorYear
Other Expenses Current Year40558351OtherExpensesCurrentYear
Total Expenses Prior Year65553404TotalExpensesPriorYear
Total Expenses Current Year68557809TotalExpensesCurrentYear
Revenues Less Expenses Prior Year-1864564RevenuesLessExpensesPriorYear
Revenues Less Expenses CY1485968RevenuesLessExpensesCY
Total Assets BOY270167888TotalAssetsBOY
Total Assets EOY267685668TotalAssetsEOY
Total Liabilities BOY358085475TotalLiabilitiesBOY
Total Liabilities EOY361102589TotalLiabilitiesEOY
Net Assets Or Fund Balances BOY-87917587NetAssetsOrFundBalancesBOY
Net Assets Or Fund Balances EOY-93416921NetAssetsOrFundBalancesEOY
Mission DescriptionMEDICAL RESEARCH ORGANIZATIONMissionDescription
Significant New Program Services0SignificantNewProgramServices
Significant Change0SignificantChange
Expense2140903Expense
Revenue0Revenue
DescriptionTHE PROGRAM FOR BIOSPECIMEN SCIENCE HAS FOCUSED ON THE CHANGE IN BIOLOGICAL PARAMETERS AND QUALITY OF BIOSPECIMENS CAUSED BY COLLECTION, PROCESSING, AND STORAGE PROCEDURES. THIS RESEARCH IDENTIFIES EFFECTS ON THE CELL BIOLOGY THAT MAY BE UNRELATED TO THE DISEASE AND MORE SO CAUSED BY THE MANAGEMENT OF THE BIOSPECIMEN. THE RESULTS CAN BE USED TO DEVELOP BEST PRACTICES IN THE MANAGEMENT OF BIOSPECIMENS AND ULTIMATELY IMPROVE THE QUALITY OF RESEARCH FINDINGS. SCHEDULE O PROVIDES FURTHER INFORMATION REGARDING THIS PROGRAM'S ACCOMPLISHMENTS.Description

Activity2 Activity2

FieldValueIRS element (for citing)
Expense1731921Expense
Revenue500Revenue
DescriptionTHE LABORATORY OF MOLECULAR ONCOLOGY HAS FOCUSED ON UNDERSTANDING THE NUMEROUS AND DIVERSE ROLES THAT MET PLAYS IN MALIGNANT PROGRESSION AND METASTASIS. SCHEDULE O PROVIDES FURTHER INFORMATION REGARDING THIS PROGRAM'S ACCOMPLISHMENTS.Description

Activity3 Activity3

FieldValueIRS element (for citing)
Expense1661508Expense
DescriptionTHE LABORATORY OF STRUCTURAL SCIENCES IS FOCUSED ON STUDYING THE STRUCTURES AND FUNCTIONS OF PROTEIN/ LIGAND COMPLEXES THAT PLAY KEY ROLES IN MAJOR HORMONE SIGNALING PATHWAYS. SEE SCHEDULE O FOR FURTHER INFORMATION ABOUT THIS PROGRAM.Description

Activity Other ActivityOther

FieldValueIRS element (for citing)
Expense39181071Expense
Grants341390Grants
Revenue2455766Revenue
FieldValueIRS element (for citing)
Total Of Other Program Service Exp39181071TotalOfOtherProgramServiceExp
Total Of Other Program Service Grnt341390TotalOfOtherProgramServiceGrnt
Total Of Other Program Service Rev2455766TotalOfOtherProgramServiceRev
Total Program Service Expense44715403TotalProgramServiceExpense
Described In501 C31DescribedIn501C3
Schedule B Required1ScheduleBRequired
Political Activities0PoliticalActivities
Lobbying Activities1LobbyingActivities
Subject To Proxy Tax0SubjectToProxyTax
Donor Advised Funds0DonorAdvisedFunds
Conservation Easements0ConservationEasements
Collections Of Art0CollectionsOfArt
Credit Counseling0CreditCounseling
Term Or Permanent Endowments0TermOrPermanentEndowments
Report Land Bldg Equip1ReportLandBldgEquip
Report Invest Oth Securities0ReportInvestOthSecurities
Report Prog Rel Invest0ReportProgRelInvest
Report Other Assets1ReportOtherAssets
Report Other Liabilities1ReportOtherLiabilities
Report Fin48 Footnote1ReportFin48Footnote
Independent Audit Financial Stmt0IndependentAuditFinancialStmt
Consolidated Audit Financial Stmt1ConsolidatedAuditFinancialStmt
School0School
Foreign Office1ForeignOffice
Foreign Activities1ForeignActivities
More Than5000 K To Organizations0MoreThan5000KToOrganizations
More Than5000 K To Individuals0MoreThan5000KToIndividuals
Professional Fundraising0ProfessionalFundraising
Fundraising Activities0FundraisingActivities
Gaming0Gaming
Hospital0Hospital
Grants To Organizations0GrantsToOrganizations
Grants To Individuals1GrantsToIndividuals
Schedule J Required1ScheduleJRequired
Tax Exempt Bonds1TaxExemptBonds
Invest Tax Exempt Bonds0InvestTaxExemptBonds
Escrow Account0EscrowAccount
On Behalf Of Issuer0OnBehalfOfIssuer
Excess Benefit Transaction0ExcessBenefitTransaction
Prior Excess Benefit Transaction0PriorExcessBenefitTransaction
Loan To Officer Or DQP0LoanToOfficerOrDQP
Grant To Related Person0GrantToRelatedPerson
Bsnss Rltnshp With Organization0BsnssRltnshpWithOrganization
Bsnss Rltnshp Thru Family Member0BsnssRltnshpThruFamilyMember
Officer Entity With Bsnss Rltnshp0OfficerEntityWithBsnssRltnshp
Deductible Non Cash Contributions0DeductibleNonCashContributions
Deductible Contributions Of Art0DeductibleContributionsOfArt
Terminated0Terminated
Partial Liquidation0PartialLiquidation
Disregarded Entity1DisregardedEntity
Related Entity1RelatedEntity
Related Org Controlled Entity1RelatedOrgControlledEntity
Transaction Related Entity1TransactionRelatedEntity
Transfers To Exempt Non Chrtbl Org0TransfersToExemptNonChrtblOrg
Activities Conducted Partnership0ActivitiesConductedPartnership
Schedule O Required1ScheduleORequired
Number Forms Transmitted With1096113NumberFormsTransmittedWith1096
Number W2 G Included0NumberW2GIncluded
Number Of Employees367NumberOfEmployees
Employment Tax Returns Filed1EmploymentTaxReturnsFiled
Unrelated Business Income1UnrelatedBusinessIncome
Form990-T Filed1Form990-TFiled
Foreign Financial Account0ForeignFinancialAccount
Prohibited Tax Shelter Trans0ProhibitedTaxShelterTrans
Taxable Party Notification0TaxablePartyNotification
Non Deductible Contributions0NonDeductibleContributions
Quid Pro Quo Contributions0QuidProQuoContributions
Form8282 Property Disposed Of0Form8282PropertyDisposedOf
Funds To Pay Premiums0FundsToPayPremiums
Premiums Paid0PremiumsPaid
Indoor Tanning Services0IndoorTanningServices
Info In Schedule O Part VIXInfoInScheduleOPartVI
Nbr Voting Governing Body Members5NbrVotingGoverningBodyMembers
Number Independent Voting Members3NumberIndependentVotingMembers
Family Or Business Relationship1FamilyOrBusinessRelationship
Delegation Of Management Duties1DelegationOfManagementDuties
Changes To Organizing Docs0ChangesToOrganizingDocs
Material Diversion Or Misuse0MaterialDiversionOrMisuse
Members Or Stockholders0MembersOrStockholders
Election Of Board Members1ElectionOfBoardMembers
Decisions Subject To Approval0DecisionsSubjectToApproval
Minutes Of Governing Body1MinutesOfGoverningBody
Minutes Of Committees1MinutesOfCommittees
Officer Mailing Address0OfficerMailingAddress
Local Chapters0LocalChapters
Form990 Provided To Governing Body1Form990ProvidedToGoverningBody
Conflict Of Interest Policy1ConflictOfInterestPolicy
Annual Disclosure Covered Persons1AnnualDisclosureCoveredPersons
Regular Monitoring Enforcement1RegularMonitoringEnforcement
Whistleblower Policy1WhistleblowerPolicy
Document Retention Policy1DocumentRetentionPolicy
Compensation Process CEO1CompensationProcessCEO
Compensation Process Other1CompensationProcessOther
Investment In Joint Venture0InvestmentInJointVenture
States Where Copy Of Return Is FiledMIStatesWhereCopyOfReturnIsFiled
Upon RequestXUponRequest

The Books Are In Care Of TheBooksAreInCareOf

Name Business NameBusiness

FieldValueIRS element (for citing)
Business Name Line1TIMOTHY J MYERS CFOBusinessNameLine1
FieldValueIRS element (for citing)
Telephone Number6162345368TelephoneNumber

Address US AddressUS

FieldValueIRS element (for citing)
Address Line1333 BOSTWICK AVENUE NEAddressLine1
CityGRAND RAPIDSCity
StateMIState
ZIP Code495032518ZIPCode
FieldValueIRS element (for citing)
Info In Schedule O Part VIIXInfoInScheduleOPartVII

Form990 Part VII Section A Form990PartVIISectionA (16 entries)

TitleTitleAverage Hours Per WeekAverageHoursPerWeekIndividual Trustee Or DirectorIndividualTrusteeOrDirectorOfficerOfficerReportable Comp From OrganizationReportableCompFromOrganizationReportable Comp From Related OrgsReportableCompFromRelatedOrgsOther CompensationOtherCompensationHighest Compensated EmployeeHighestCompensatedEmployee
DAVID VAN ANDEL
CHAIRMAN / CEO28.00XX4114670122461
DR GEORGE VANDE WOUDE
TRUSTEE/ DIST INVESTIGATOR50.00X299763025940
DR JAMES FAHNER
TRUSTEE1.00X1000000
DR FRITZ ROTTMAN PHD
TRUSTEE1.00X1000020000
DR JEFFREY TRENTTHROUGH 312
PRESIDENT & RESEARCH DIRECTOR50.00XX11807390243940
WILLIAM POST THROUGH 312
TRUSTEE1.00X200000
DR GARY TARPLEY
TRUSTEE1.00X000
R JACK FRICK THROUGH 1211
CHIEF ADMINISTRATIVE OFFICER50.00X275769095458
TIMOTHY MYERS
CHIEF FINANCIAL OFFICER50.00X237174078801
DAVID WHITESCARVER
SECRETARY/ CHIEF LEGAL OFFICER50.00X197281049962
DR JANA HALL
CHIEF OPERATIONS OFFICER50.00X000
DR H ERIC XU
DIST INVESTIGATOR45.00294385049433X
JOHN BENDER
CLINICAL OPERATIONS DIRECTOR45.00235889049192X
BRYON CAMPBELL
CHIEF INFORMATION OFFICER45.00191590035484X
DR GISELLE SAULNIER SHOLLER
DIST INVESTIGATOR45.00222748034912X
DR SCOTT JEWELL
DIST INVESTIGATOR45.00296776065194X
FieldValueIRS element (for citing)
Total Reportable Comp From Org3865581TotalReportableCompFromOrg
Total Reportable Comp Frm Rltd Orgs2000TotalReportableCompFrmRltdOrgs
Total Other Compensation850777TotalOtherCompensation
Number Individuals GT100 K43NumberIndividualsGT100K
Formers Listed0FormersListed
Total Comp GT150 K1TotalCompGT150K
Compensation From Other Sources0CompensationFromOtherSources

Contractor Compensation ContractorCompensation (5 entries)

Address Line1AddressOfContractor/AddressUS/AddressLine1CityAddressOfContractor/AddressUS/CityStateAddressOfContractor/AddressUS/StateZIP CodeAddressOfContractor/AddressUS/ZIPCodeDescription Of ServicesDescriptionOfServicesCompensationCompensation
BANK OF AMERICAMERRILL LYNCH
100 N TRYON STCHARLOTTENC28202CREDIT ENHANCEMENT FEES3384333
AON RISK SERVICES CENTER INC
75 REMITTANCE DR STE 1943CHICAGOIL606751943INSURANCE551182
WARNER NORCROSS & JUDD
111 LYON ST 900 OLD KENTGRAND RAPIDSMI495032487LEGAL/ CONSULTING547737
PRIORITY HEALTH
1686 RELIABLE PARKWAYCHICAGOIL60686HEALTH INSURANCE ADMIN464179
DK SECURITY
5160 FALCONVIEW AVE SE KENTWOODKENTWOODMI49512SECURITY SERVICES370952
FieldValueIRS element (for citing)
Number Of Contractors GT100 K19NumberOfContractorsGT100K
Related Organizations47258660RelatedOrganizations
Government Grants6031998GovernmentGrants
All Other Contributions4706366AllOtherContributions
Noncash Contributions12000NoncashContributions
Total Contributions57997024TotalContributions

Program Service Revenue ProgramServiceRevenue

FieldValueIRS element (for citing)
DescriptionRESEARCH BILLED REVDescription
Business Code541700BusinessCode
Total Revenue Column1242591TotalRevenueColumn
Related Or Exempt Function Income345420RelatedOrExemptFunctionIncome
Unrelated Business Revenue897171UnrelatedBusinessRevenue
FieldValueIRS element (for citing)
Total Program Service Revenue1242591TotalProgramServiceRevenue

Investment Income InvestmentIncome

FieldValueIRS element (for citing)
Total Revenue Column214931TotalRevenueColumn
Exclusion$214,931ExclusionAmount

Royalties Revenue RoyaltiesRevenue

FieldValueIRS element (for citing)
Total Revenue Column253826TotalRevenueColumn
Exclusion$253,826ExclusionAmount

Gross Rents GrossRents

FieldValueIRS element (for citing)
Real2602254Real
Personal1308Personal

Less Rental Expenses LessRentalExpenses

FieldValueIRS element (for citing)
Real1506788Real
Personal806Personal

Rental Income Or Loss RentalIncomeOrLoss

FieldValueIRS element (for citing)
Real1095466Real
Personal502Personal

Net Rental Income Or Loss NetRentalIncomeOrLoss

FieldValueIRS element (for citing)
Total Revenue Column1095968TotalRevenueColumn
Related Or Exempt Function Income1095466RelatedOrExemptFunctionIncome
Unrelated Business Revenue502UnrelatedBusinessRevenue

Gross Amount Sales Assets GrossAmountSalesAssets

FieldValueIRS element (for citing)
Other618644Other

Less Cost Oth Basis Sales Expenses LessCostOthBasisSalesExpenses

FieldValueIRS element (for citing)
Other500435Other

Gain Or Loss GainOrLoss

FieldValueIRS element (for citing)
Other118209Other

Net Gain Or Loss Investments NetGainOrLossInvestments

FieldValueIRS element (for citing)
Total Revenue Column118209TotalRevenueColumn
Related Or Exempt Function Income118209RelatedOrExemptFunctionIncome

Other Revenue Misc OtherRevenueMisc (2 entries)

DescriptionDescriptionBusiness CodeBusinessCodeTotal Revenue ColumnTotalRevenueColumnExclusionExclusionAmount
REL. PARTY ADMIN SUPPO5610005425172$5,425,172
REIMBURSED EXPENSES9000993654325$3,654,325

Miscellaneous Revenue MiscellaneousRevenue

FieldValueIRS element (for citing)
Total Revenue Column41731TotalRevenueColumn
Exclusion$41,731ExclusionAmount
FieldValueIRS element (for citing)
Total Other Revenue9121228TotalOtherRevenue

Total Revenue TotalRevenue

FieldValueIRS element (for citing)
Total Revenue Column70043777TotalRevenueColumn
Related Or Exempt Function Income1559095RelatedOrExemptFunctionIncome
Unrelated Business Revenue897673UnrelatedBusinessRevenue
Exclusion$9,589,985ExclusionAmount

Grants To Domestic Individuals GrantsToDomesticIndividuals

FieldValueIRS element (for citing)
Total341390Total
Program Services341390ProgramServices

Comp Current Officers Directors CompCurrentOfficersDirectors

FieldValueIRS element (for citing)
Total2248987Total
Program Services1128006ProgramServices
Management And General1120981ManagementAndGeneral

Other Salaries And Wages OtherSalariesAndWages

FieldValueIRS element (for citing)
Total19866298Total
Program Services10781536ProgramServices
Management And General8793980ManagementAndGeneral
Fundraising290782Fundraising

Pension Plan Contributions PensionPlanContributions

FieldValueIRS element (for citing)
Total1515029Total
Program Services841171ProgramServices
Management And General651804ManagementAndGeneral
Fundraising22054Fundraising

Other Employee Benefits OtherEmployeeBenefits

FieldValueIRS element (for citing)
Total2549100Total
Program Services1413005ProgramServices
Management And General1098522ManagementAndGeneral
Fundraising37573Fundraising

Payroll Taxes PayrollTaxes

FieldValueIRS element (for citing)
Total1478654Total
Program Services818280ProgramServices
Management And General638320ManagementAndGeneral
Fundraising22054Fundraising

Fees For Services Legal FeesForServicesLegal

FieldValueIRS element (for citing)
Total926115Total
Program Services55923ProgramServices
Management And General870192ManagementAndGeneral

Fees For Services Accounting FeesForServicesAccounting

FieldValueIRS element (for citing)
Total132611Total
Program Services15194ProgramServices
Management And General117417ManagementAndGeneral

Fees For Services Lobbying FeesForServicesLobbying

FieldValueIRS element (for citing)
Total68133Total
Management And General68133ManagementAndGeneral

Fees For Services Other FeesForServicesOther

FieldValueIRS element (for citing)
Total2245213Total
Program Services1495233ProgramServices
Management And General749980ManagementAndGeneral

Advertising Advertising

FieldValueIRS element (for citing)
Total709562Total
Program Services10046ProgramServices
Management And General699516ManagementAndGeneral

Office Expenses OfficeExpenses

FieldValueIRS element (for citing)
Total136899Total
Program Services77504ProgramServices
Management And General59395ManagementAndGeneral

Information Technology InformationTechnology

FieldValueIRS element (for citing)
Total366110Total
Program Services155278ProgramServices
Management And General210832ManagementAndGeneral

Occupancy Occupancy

FieldValueIRS element (for citing)
Total2448990Total
Program Services1904532ProgramServices
Management And General544458ManagementAndGeneral

Travel Travel

FieldValueIRS element (for citing)
Total695945Total
Program Services445065ProgramServices
Management And General250880ManagementAndGeneral

Conferences Meetings ConferencesMeetings

FieldValueIRS element (for citing)
Total164918Total
Program Services91507ProgramServices
Management And General73411ManagementAndGeneral

Interest Interest

FieldValueIRS element (for citing)
Total11375530Total
Program Services8869107ProgramServices
Management And General2506423ManagementAndGeneral

Depreciation Depletion DepreciationDepletion

FieldValueIRS element (for citing)
Total9970658Total
Program Services8061216ProgramServices
Management And General1909442ManagementAndGeneral

Insurance Insurance

FieldValueIRS element (for citing)
Total440991Total
Program Services289362ProgramServices
Management And General151629ManagementAndGeneral

Other Expenses OtherExpenses (4 entries)

DescriptionDescriptionTotalTotalProgram ServicesProgramServicesManagement And GeneralManagementAndGeneral
LAB SUPPLIES & SERVICES32488733248873
EQUIPMENT & SOFTWARE20331961077077956119
OTHER SCIENTIFIC11431541143154
SCIENTIFIC PURCH. SVC.663483663483

All Other Expenses AllOtherExpenses

FieldValueIRS element (for citing)
Total3787970Total
Program Services1789461ProgramServices
Management And General1958799ManagementAndGeneral
Fundraising39710Fundraising

Total Functional Expenses TotalFunctionalExpenses

FieldValueIRS element (for citing)
Total68557809Total
Program Services44715403ProgramServices
Management And General23430233ManagementAndGeneral
Fundraising412173Fundraising

Savings And Temp Cash Investments SavingsAndTempCashInvestments

FieldValueIRS element (for citing)
BOY954773BOY
EOY1687416EOY

Pledges And Grants Receivable PledgesAndGrantsReceivable

FieldValueIRS element (for citing)
BOY1194099BOY
EOY2507373EOY

Accounts Receivable AccountsReceivable

FieldValueIRS element (for citing)
BOY2551038BOY
EOY1262403EOY

Other Notes Loans Receivable Net OtherNotesLoansReceivableNet

FieldValueIRS element (for citing)
BOY1664455BOY
EOY1647915EOY

Prepaid Expenses Deferred Charges PrepaidExpensesDeferredCharges

FieldValueIRS element (for citing)
BOY1271897BOY
EOY1153469EOY
FieldValueIRS element (for citing)
Land Buildings Equipment Basis266334661LandBuildingsEquipmentBasis
Land Bldg Equipment Accum Deprec62385484LandBldgEquipmentAccumDeprec

Land Buildings Equipment Basis Net LandBuildingsEquipmentBasisNet

FieldValueIRS element (for citing)
BOY210880670BOY
EOY203949177EOY

Investments Other Securities InvestmentsOtherSecurities

FieldValueIRS element (for citing)
BOY1367061BOY
EOY1431848EOY

Investments Program Related InvestmentsProgramRelated

FieldValueIRS element (for citing)
BOY97917BOY
EOY0EOY

Other Assets Total OtherAssetsTotal

FieldValueIRS element (for citing)
BOY50185978BOY
EOY54046067EOY

Total Assets TotalAssets

FieldValueIRS element (for citing)
BOY270167888BOY
EOY267685668EOY

Accounts Payable Accrued Expenses AccountsPayableAccruedExpenses

FieldValueIRS element (for citing)
BOY55926177BOY
EOY61769366EOY

Deferred Revenue DeferredRevenue

FieldValueIRS element (for citing)
BOY1756331BOY
EOY388625EOY

Tax Exempt Bond Liabilities TaxExemptBondLiabilities

FieldValueIRS element (for citing)
BOY220385000BOY
EOY221189000EOY

Other Liabilities OtherLiabilities

FieldValueIRS element (for citing)
BOY80017967BOY
EOY77755598EOY

Total Liabilities TotalLiabilities

FieldValueIRS element (for citing)
BOY358085475BOY
EOY361102589EOY
FieldValueIRS element (for citing)
Follow SFAS117XFollowSFAS117

Unrestricted Net Assets UnrestrictedNetAssets

FieldValueIRS element (for citing)
BOY-80494164BOY
EOY-95108778EOY

Temporarily Restricted Net Assets TemporarilyRestrictedNetAssets

FieldValueIRS element (for citing)
BOY-7425523BOY
EOY1689257EOY

Permanently Restricted Net Assets PermanentlyRestrictedNetAssets

FieldValueIRS element (for citing)
BOY2100BOY
EOY2600EOY

Total Net Assets Fund Balances TotalNetAssetsFundBalances

FieldValueIRS element (for citing)
BOY-87917587BOY
EOY-93416921EOY

Total Liab Net Assets Fund Balances TotalLiabNetAssetsFundBalances

FieldValueIRS element (for citing)
BOY270167888BOY
EOY267685668EOY
FieldValueIRS element (for citing)
Info In Schedule O Part XIXInfoInScheduleOPartXI
Reconcilation Revenue Expenses1485968ReconcilationRevenueExpenses
Reconcilation Other Changes-6985302ReconcilationOtherChanges
Info In Schedule O Part XIIXInfoInScheduleOPartXII
Method Of Accounting AccrualXMethodOfAccountingAccrual
Accountant Compile Or Review0AccountantCompileOrReview
FS Audited1FSAudited
Audit Committee1AuditCommittee
Financial Statement ConsolidatedXFinancialStatementConsolidated
Federal Grant Audit Required1FederalGrantAuditRequired
Federal Grant Audit Performed1FederalGrantAuditPerformed

Schedule A IRS990ScheduleA

FieldValueIRS element (for citing)
Medical Research Org170b1 AiiiXMedicalResearchOrg170b1Aiii

Hospital Name And Address HospitalNameAndAddress

Name Name

FieldValueIRS element (for citing)
Business Name Line1SPECTRUM HEALTHBusinessNameLine1
FieldValueIRS element (for citing)
CityGRAND RAPIDSCity
StateMIState

Schedule B IRS990ScheduleB

Contributor Info ContributorInfo

FieldValueIRS element (for citing)
Contributor NumberRESTRICTEDContributorNumber

Contributor Name Business ContributorNameBusiness

FieldValueIRS element (for citing)
Business Name Line1RESTRICTEDBusinessNameLine1

Contributor Address US ContributorAddressUS

FieldValueIRS element (for citing)
Address Line1RESTRICTEDAddressLine1
Address Line2RESTRICTEDAddressLine2
CityRESTRICTEDCity
StateRESTRICTEDState
ZIP CodeRESTRICTEDZIPCode
FieldValueIRS element (for citing)
Aggregate ContributionsRESTRICTEDAggregateContributions

Schedule C IRS990ScheduleC

Total Grassroots Lobbying TotalGrassrootsLobbying

FieldValueIRS element (for citing)
Filing Organizations Totals0FilingOrganizationsTotals

Total Direct Lobbying TotalDirectLobbying

FieldValueIRS element (for citing)
Filing Organizations Totals68133FilingOrganizationsTotals

Total Lobbying Expenditures TotalLobbyingExpenditures

FieldValueIRS element (for citing)
Filing Organizations Totals68133FilingOrganizationsTotals

Other Exempt Purpose Expenditures OtherExemptPurposeExpenditures

FieldValueIRS element (for citing)
Filing Organizations Totals68489676FilingOrganizationsTotals

Total Exempt Purpose Expenditures TotalExemptPurposeExpenditures

FieldValueIRS element (for citing)
Filing Organizations Totals68557809FilingOrganizationsTotals

Lobbying Nontaxable LobbyingNontaxableAmount

FieldValueIRS element (for citing)
Filing Organizations Totals1000000FilingOrganizationsTotals

Grassroots Nontaxable GrassrootsNontaxableAmount

FieldValueIRS element (for citing)
Filing Organizations Totals250000FilingOrganizationsTotals

Tot Lobbying Grassroot Minus Non Tx TotLobbyingGrassrootMinusNonTx

FieldValueIRS element (for citing)
Filing Organizations Totals0FilingOrganizationsTotals

Tot Lobby Expend Mns Lobbying Nontx TotLobbyExpendMnsLobbyingNontx

FieldValueIRS element (for citing)
Filing Organizations Totals0FilingOrganizationsTotals

Lobbying Nontaxable Amount2 LobbyingNontaxableAmount2

FieldValueIRS element (for citing)
Current Year1000000CurrentYear
Total1000000Total
FieldValueIRS element (for citing)
Lobbying Ceiling$1,500,000LobbyingCeilingAmount

Total Lobbying Expenditures2 TotalLobbyingExpenditures2

FieldValueIRS element (for citing)
Current Year68133CurrentYear
Total68133Total

Grassroots Nontaxable Amount2 GrassrootsNontaxableAmount2

FieldValueIRS element (for citing)
Current Year250000CurrentYear
Total250000Total
FieldValueIRS element (for citing)
Grassroots Ceiling$375,000GrassrootsCeilingAmount

Form990 Schedule C Part IV Form990ScheduleCPartIV

FieldValueIRS element (for citing)
IdentifierPART IV, SUPPLEMENTAL INFORMATION:Identifier
ExplanationVARI EMPLOYEES MANAGE RELATIONSHIPS WITH OUTSIDE CONSULTANTS AND DID NOT PARTICIPATE IN DIRECT LOBBYING. THEREFORE, NO COMPENSATION EXPENSE HAS BEEN ALLOCATED TO LOBBYING EXPENSE.Explanation

Schedule D IRS990ScheduleD

FieldValueIRS element (for citing)
Collect Used For Public ExhibitionXCollectUsedForPublicExhibition
Endowments Held By Related Orgs1EndowmentsHeldByRelatedOrgs
Are Related Orgs Listed Schedule R1AreRelatedOrgsListedScheduleR

Land Land

FieldValueIRS element (for citing)
Other Cost Or Other Basis5288315OtherCostOrOtherBasis
Book Value5288315BookValue

Buildings Buildings

FieldValueIRS element (for citing)
Other Cost Or Other Basis218645316OtherCostOrOtherBasis
Depreciation32192644Depreciation
Book Value186452672BookValue

Equipment Equipment

FieldValueIRS element (for citing)
Other Cost Or Other Basis40708927OtherCostOrOtherBasis
Depreciation30154521Depreciation
Book Value10554406BookValue

Other Land Buildings OtherLandBuildings

FieldValueIRS element (for citing)
Other Cost Or Other Basis1692103OtherCostOrOtherBasis
Depreciation38319Depreciation
Book Value1653784BookValue
FieldValueIRS element (for citing)
Total Of Book Value Land Buildings203949177TotalOfBookValueLandBuildings

Other Assets OtherAssets (2 entries)

DescriptionDescriptionBook ValueBookValue
BOND ISSUANCE COSTS NET OF ACCUMULATED AMORTIZATION1516067
PLEDGED SECURITIES52530000
FieldValueIRS element (for citing)
Total Book Value Other Assets54046067TotalBookValueOtherAssets

Other Liabilities OtherLiabilities (4 entries)

DescriptionDescriptionAmountAmount
ACCRUED POSTRETIREMENT BENEFIT OBLIGATION$1,524,181
UNREALIZED LOSS ON BOND SWAP$69,959,449
MSU COLLEGE OF HUMAN MEDICINE- CONTRIBUTION PAYABLE$6,205,908
CAPITAL LEASE$66,060
FieldValueIRS element (for citing)
Total Of Amounts77755598TotalOfAmounts
Total Revenue70043777TotalRevenue
Total Expenses68557809TotalExpenses
Excess Or Deficit For Year1485968ExcessOrDeficitForYear
Net Unrealized GL On Investments64787NetUnrealizedGLOnInvestments
Other-$7,050,089OtherAmount
Total Adjustments-6985302TotalAdjustments
Excess Or Deficit Per FS-5499334ExcessOrDeficitPerFS
Tot Revenue Etc Audited Fincl Stmt64297349TotRevenueEtcAuditedFinclStmt
Net Unrealized Gains Investments64787NetUnrealizedGainsInvestments
Other Revenues100790OtherRevenues
Revenue Not Rptd F990165577RevenueNotRptdF990
Revenue Subtotal64131772RevenueSubtotal
Other Revenues Not Included5912006OtherRevenuesNotIncluded
Revenue Not Rptd On Fin Stmt5912006RevenueNotRptdOnFinStmt
Total Revenue Per Form99070043778TotalRevenuePerForm990
Tot Expenses Etc Audited Fincl Stmt69796683TotExpensesEtcAuditedFinclStmt
Other Expenses Included7150879OtherExpensesIncluded
Expenses Not Rptd F9907150879ExpensesNotRptdF990
Expenses Subtotal62645804ExpensesSubtotal
Other Expenses Not Included5912006OtherExpensesNotIncluded
Expenses Not Rptd On Fin Stmt5912006ExpensesNotRptdOnFinStmt
Total Expenses Per Form99068557810TotalExpensesPerForm990

Form990 Schedule D Part XIV Form990ScheduleDPartXIV (5 entries)

IdentifierIdentifierReturn ReferenceReturnReferenceExplanationExplanation
DESCRIPTION OF INTENDED USE OF ENDOWMENT FUNDS:PART V, LINE 4:TO SUPPORT THE CORE RESEARCH OF VARI BY SUPPLYING A STEADY SOURCE OF INCOME FOR ITS OPERATING EXPENDITURES.
PART XI, LINE 8 - OTHER ADJUSTMENTS:LOSS ON INTEREST RATE SWAP -7,050,089.
PART X, LINE 1(1) AND LINE 2: MANAGEMENT BELIEVES THE LIKELIHOOD VARI, OR ANY RELATED ORGANIZATION, WILL BE REQUIRED TO MAKE ANY ADDITIONAL PAYMENTS IS REMOTE. PART XI, LINE 8: NET LOSS RELATED TO THE INTEREST RATE SWAP. PART XII, LINE 2D: RECLASS OF TRANSMED SYSTEMS (A RELATED PARTY) COST OF GOODS SOLD TO PRESENT ON STATEMENT OF REVENUE RATHER THAN STATEMENT OF FUNCTIONAL EXPENSES. PART XIII, LINE 2D: INCLUDES BOTH THE NET LOSS RELATED TO THE INTEREST RATE SWAP AND RECLASS OF TRANSMED SYSTEMS COST OF GOODS SOLD TO PRESENT ON STATEMENT OF REVENUE RATHER THAN STATEMENT OF FUNCTIONAL EXPENSES.
PART XII AND XIII, LINE 4B: EXPENSE ALLOCATIONS PRESENTED WITHIN REVENUE.
PART V - ALL ENDOWMENT FUNDS ARE HELD AT THE VAN ANDEL INSTITUTE (A RELATED ORGANIZATION).

Schedule F IRS990ScheduleF

FieldValueIRS element (for citing)
Grant Records Maintained1GrantRecordsMaintained

Accts Actvs Out US Table AcctsActvsOutUSTable

FieldValueIRS element (for citing)
RegionEAST ASIA & THE PACIFICRegion
Number Of Offices0NumberOfOffices
Number Of Employees2NumberOfEmployees
Type Of Activities ConductedPROGRAM SERVICESTypeOfActivitiesConducted
Specific Services ProvidedRESEARCH COLLABORATION - RESEARCH SERVICESSpecificServicesProvided
Total Expenditures455219TotalExpenditures
FieldValueIRS element (for citing)
Subtotal Number Of Offices0SubtotalNumberOfOffices
Subtotal Number Of Employees2SubtotalNumberOfEmployees
Cont Number Of Offices0ContNumberOfOffices
Cont Number Of Employees0ContNumberOfEmployees
Total Number Of Offices0TotalNumberOfOffices
Total Number Of Employees2TotalNumberOfEmployees
Subtotal Amount Spent455219SubtotalAmountSpent
Cont Amount Spent0ContAmountSpent
Total Amount Spent455219TotalAmountSpent
Transfer To Foreign Corp0TransferToForeignCorp
Interest In Foreign Trust0InterestInForeignTrust
Own Foreign Corp0OwnForeignCorp
Passive Foreign Invest Co0PassiveForeignInvestCo
Foreign Partnership0ForeignPartnership
Boycott Countries0BoycottCountries

Schedule I IRS990ScheduleI

FieldValueIRS element (for citing)
Records Maintained1RecordsMaintained

Form990 Schedule I Part III Form990ScheduleIPartIII (2 entries)

Type Of GrantTypeOfGrantNumber Of RecipientsNumberOfRecipientsAmount Of Cash GrantAmountOfCashGrantAmount Of Non Cash AssistanceAmountOfNonCashAssistanceMethod Of ValuationMethodOfValuation
GRADUATE STUDENT STIPENDS FOR VAN ANDEL GRADUATE SCHOOL AND MICHIGAN STATE UNIVERSITY STUDENTS819841012000TUITION PAID
FOREIGN NATIONAL STUDENT STIPENDS13105980

Form990 Schedule I Part IV Form990ScheduleIPartIV

FieldValueIRS element (for citing)
ExplanationSCHEDULE I, PART I, LINE 2: STIPENDS ARE PROVIDED TO THE RESEARCH STUDENTS FOR LIVING AND INSURANCE ASSISTANCE.Explanation

Schedule J IRS990ScheduleJ

FieldValueIRS element (for citing)
First Class Or Charter TravelXFirstClassOrCharterTravel
Housing Allowance Or ResidenceXHousingAllowanceOrResidence
Written Policy Re T And E Expenses0WrittenPolicyReTAndEExpenses
Substantiation Required1SubstantiationRequired
Compensation CommitteeXCompensationCommittee
Independent ConsultantXIndependentConsultant
Written Employment ContractXWrittenEmploymentContract
Compensation SurveyXCompensationSurvey
Board Or Committee ApprovalXBoardOrCommitteeApproval
Severance Payment0SeverancePayment
Supplemental Nonqual Retire Plan0SupplementalNonqualRetirePlan
Equity Based Comp Arrangement0EquityBasedCompArrangement
Comp Based On Revenue Of Filing Org0CompBasedOnRevenueOfFilingOrg
Comp Based On Revenue Related Orgs0CompBasedOnRevenueRelatedOrgs
Comp Based Net Earnings Filing Org0CompBasedNetEarningsFilingOrg
Comp Based Net Earnings Relate Orgs0CompBasedNetEarningsRelateOrgs
Any Non Fixed Payments1AnyNonFixedPayments
Initial Contract Exception0InitialContractException

Form990 Schedule J Part II Form990ScheduleJPartII (11 entries)

Base Compensation Filing OrgBaseCompensationFilingOrgComp Based On Related OrgsCompBasedOnRelatedOrgsBonus Filing OrgBonusFilingOrgBonus Related OrgsBonusRelatedOrgsOther Compensation Filing OrgOtherCompensationFilingOrgOther Compensation Related OrgsOtherCompensationRelatedOrgsDeferred Comp Filing OrgDeferredCompFilingOrgDeferred Comp Related OrgsDeferredCompRelatedOrgsNontaxable Benefits Filing OrgNontaxableBenefitsFilingOrgNontaxable Benefits Related OrgsNontaxableBenefitsRelatedOrgsTotal Compensation Filing OrgTotalCompensationFilingOrgTotal Compensation Related OrgsTotalCompensationRelatedOrgsComp Report Prior990 Filing OrgCompReportPrior990FilingOrgComp Report Prior990 Related OrgsCompReportPrior990RelatedOrgs
DAVID VAN ANDEL
3000140864040250490121954050705339280864040
DR GEORGE VANDE WOUDE
258791022000018972024500014400325703000
DR JEFFREY TRENTTHROUGH 312
83713602482560953470242500014400142467902482560
R JACK FRICK THROUGH 1211
219566054223019800863200913803712270542230
TIMOTHY MYERS
18024705662703000696630913803159750566270
DAVID WHITESCARVER
10137200095909046154038080247243000
DR H ERIC XU
25877803515704500402950913803438180222510
JOHN BENDER
20768007590020619040055091370285081075900
BRYON CAMPBELL
17666801423206900263470913702270740142320
DR GISELLE SAULNIER SHOLLER
1459420200000568060288210609102576600200000
DR SCOTT JEWELL
254861040625012900560570913703619700406250

Form990 Schedule J Part III Form990ScheduleJPartIII (3 entries)

Return ReferenceReturnReferenceExplanationExplanation
PART I, LINE 1AVARI ALLOWS FOR FIRST-CLASS OR CHARTER TRAVEL FOR OFFICERS AND TRUSTEES. PART I, LINE 1B: HOUSING ALLOWANCE AND RESIDENCE FOR PERSONAL USE ARE MANAGED BY HUMAN RESOURCES ON A CASE BY CASE BASIS, BOTH OF WHICH EXCLUSIVELY OCCUR IN CONNECTION WITH RELOCATION TO GRAND RAPIDS.
PART I, LINE 1BA WRITTEN POLICY IS IN PLACE FOR FIRST CLASS/ CHARTER TRAVEL.
PART I, LINE 7ALL OFFICERS AND OTHER HIGHLY COMPENSATED EMPLOYEES ARE INCLUDED IN A VARIABLE PAY PLAN BASED ON ACHIEVEMENTS OF THE ORGANIZATION AS WELL AS RESPECTIVE INDIVIDUAL PREDETERMINED GOALS AND OBJECTIVES.

Schedule K IRS990ScheduleK

Form990 Schedule K Part I Form990ScheduleKPartI

Issuer Name IssuerName

FieldValueIRS element (for citing)
Business Name Line1MICHIGAN STRATEGIC FUND LIMITED OBLIGATION REVENUEBusinessNameLine1
FieldValueIRS element (for citing)
Issuer EIN521417332IssuerEIN
CUSIP Number594698EG3CUSIPNumber
Date Issued2008-04-10DateIssued
Issue Price220000000IssuePrice
Description Of PurposeBUILD, EQUIP & FURNISH PHASE II RESEARCH FACILITY, & REFUND $50M PRIOR LTDDescriptionOfPurpose
Defeased0Defeased
On Behalf Of Issuer0OnBehalfOfIssuer
Pool Financing0PoolFinancing

Form990 Schedule K Part II Form990ScheduleKPartII

FieldValueIRS element (for citing)
Total Proceeds223154512TotalProceeds
Capital Expenditures113036720CapitalExpenditures
Other Spent Proceeds110117792OtherSpentProceeds
Year Of Subst Completion2009YearOfSubstCompletion
Current Refunding1CurrentRefunding
Advance Refunding0AdvanceRefunding
Final Allocation Made1FinalAllocationMade
Adequate Books And Recds Maintaind1AdequateBooksAndRecdsMaintaind

Form990 Schedule K Part III Form990ScheduleKPartIII

FieldValueIRS element (for citing)
Owning Bond Financed Property0OwningBondFinancedProperty
Any Lease Arrangements1AnyLeaseArrangements
Mngment Cntrct Bond Financd Prprty1MngmentCntrctBondFinancdPrprty
Engage Bond Counsel Contracts1EngageBondCounselContracts
Any Research Agreements1AnyResearchAgreements
Engage Bond Counsel Research1EngageBondCounselResearch
Percentage Of Prvt Business Re UBI0.01090PercentageOfPrvtBusinessReUBI
Total Private Business Use0.01090TotalPrivateBusinessUse
Post Issuance Compliance Procdrs1PostIssuanceComplianceProcdrs

Form990 Schedule K Part IV Form990ScheduleKPartIV

FieldValueIRS element (for citing)
Form8038 T Filed1Form8038TFiled
Variable Rate Issue1VariableRateIssue
Hedge Identified In Books And Recds0HedgeIdentifiedInBooksAndRecds
Gross Proceeds Invested In GIC0GrossProceedsInvestedInGIC
Gross Proceeds Invested0GrossProceedsInvested
Exception To Rebate0ExceptionToRebate
FieldValueIRS element (for citing)
Fed Tax Requirements ComplianceXFedTaxRequirementsCompliance

Schedule O IRS990ScheduleO

General Explanation GeneralExplanation (16 entries)

Return ReferenceReturnReferenceExplanationExplanationIdentifierIdentifier
FORM 990, PART VI, SECTION A, LINE 2VARI AND VAEI SHARE COMMON MANAGEMENT. AS OFFICERS OF VARI, DAVID VAN ANDEL, R. JACK FRICK, DR. JANA HALL, TIMOTHY MYERS AND DAVID WHITESCARVER INTERACT AND WORK TOGETHER WITH STEVE TRIEZENBERG, AN OFFICER OF VAEI.
FORM 990, PART VI, SECTION A, LINE 2VARI AND THE TRANSLATIONAL GENOMICS INSTITUTE (TGEN) SHARED COMMON GOVERNANCE. DR. WILLIAM J. POST, DR. JOSE CARDENAS, AND DR. JEFF TRENT ALL SERVED AS DIRECTORS FOR BOTH VARI AND TGEN (A RELATED ORGANIZATION). AS OF MARCH 12, 2012, VARI AND TGEN TERMINATED THEIR ALLIANCE AND AFFILIATION AGREEMENT.
FORM 990, PART VI, SECTION A, LINE 3DURING THE FISCAL YEAR, JERRY CALLAHAN, AN INDEPENDENT CONTRACTOR, SERVED AS THE VICE PRESIDENT OF BUSINESS DEVELOPMENT AND EXTRAMURAL ADMINISTRATION. AS OF JANUARY 2013, MR. CALLAHAN BECAME A FULL TIME EMPLOYEE.
FORM 990, PART VI, SECTION A, LINE 7ATHE TRUSTEES OF VAN ANDEL INSTITUTE HAVE THE AUTHORITY TO ELECT ONE OR MORE MEMBERS OF VARI'S GOVERNING BODY.
FORM 990, PART VI, SECTION B, LINE 11FOLLOWING COMPLETION OF THE FINANCIAL STATEMENT AUDIT, THE FORM 990 IS PREPARED AND REVIEWED BY MANAGEMENT. IT IS THEN CIRCULATED TO THE FULL BOARD FOR REVIEW AND FINAL APPROVAL PRIOR TO FILING WITH THE IRS.
FORM 990, PART VI, SECTION B, LINE 12CVARI HAS A WRITTEN CONFLICT OF INTEREST POLICY FOR WHICH THE ORGANIZATION ENFORCES A PROCESS TO IDENTIFY, EVALUATE, AND CORRECT OR REMOVE POTENTIAL CONFLICTS OF INTEREST. THIS POLICY HAS BEEN BOARD APPROVED. THE VAN ANDEL INSTITUTE ADMINISTERS THE CONFLICT OF INTEREST (COI) POLICY, ON BEHALF OF VARI, THROUGH TWO COMMITTEES: THE CONFLICTS COMMITTEE ("CC") AND THE INSTITUTIONAL COI COMMITTEE ("ICOIC"). THE COI POLICY SERVES AS GUIDE FOR ALL STAFF MEMBERS OF THE ORGANIZATION. THE POLICY IS INTENDED TO 1) PROVIDE STAFF WITH A USEFUL RESOURCE WHEN DEVELOPING ACTIVITIES WITH OUTSIDE INDUSTRY AND 2) PROVIDE ASSURANCE TO STAFF THAT THERE IS A COMMITTEE TO REVIEW AND RESOLVE POTENTIAL CONFLICTS OF INTEREST IF / WHEN THEY ARISE. THE CC, CHAIRED BY THE DIRECTOR OF COMPLIANCE, GENERATES AN ANNUAL DISCLOSURE QUESTIONNAIRE DISTRIBUTED TO ALL STAFF TO ENFORCE THE POLICY. THE CC IS RESPONSIBLE FOR MAKING RECOMMENDATIONS TO THE DIRECTOR. RESOLUTIONS ARE IMPLEMENTED WITH APPROVAL OF THE COMMITTEE AND IN DISCUSSION WITH THE CHAIRMAN. THE COI POLICY ALSO SERVES AS A GUIDE FOR ALL MEMBERS OF THE BOARD OF TRUSTEES AND SENIOR EXECUTIVES. THE ICOIC REQUIRES TRUSTEES TO COMPLETE AN ANNUAL DISCLOSURE STATEMENT. THIS STATEMENT AFFIRMS THEIR UNDERSTANDING OF THE POLICY, REQUIRES THEIR ACKNOWLEDGEMENT OF THE ORGANIZATION'S NONPROFIT STATUS, AND REQUESTS DISCLOSURE IF / WHEN POTENTIAL CONFLICTS ARISE. IN THE EVENT A POTENTIAL CONFLICT ARISES AT THE BOARD OR SENIOR OFFICER LEVEL, THE CHIEF LEGAL OFFICE REVIEWS AND MEETS WITH THE BOARD OF TRUSTEES TO RESOLVE POTENTIAL CONFLICTS.
FORM 990, PART VI, SECTION B, LINE 15COMPARABILITY DATA FROM EXPERT, THIRD PARTY IS OBTAINED AND REVIEWED BY VAN ANDEL INSTITUTE'S INDEPENDENT COMPENSATION COMMITTEE TO DETERMINE APPROPRIATE COMPENSATION FOR THE CEO, EXECUTIVE MANAGEMENT OFFICIALS, EXECUTIVE DIRECTOR, OFFICERS, AND KEY EMPLOYEES, ON BEHALF OF VAN ANDEL RESEARCH INSTITUTE.
FORM 990, PART VI, SECTION C, LINE 19THE CONFLICT OF INTEREST POLICY AND FINANCIAL STATEMENTS ARE AVAILABLE TO THE PUBLIC UPON REQUEST.
FORM 990, PART VII, PAGE 7DAVID VAN ANDEL, R. JACK FRICK, DR. JANA HALL, TIMOTHY MYERS, AND DAVID WHITESCARVER ALSO PERFORMED WORK FOR VAN ANDEL INSTITUTE, VAN ANDEL EDUCATION INSTITUTE, AND VAN ANDEL INSTITUTE GRADUATE SCHOOL (RELATED ENTITIES).
FORM 990, PART XI, LINE 5:NET UNREALIZED GAINS ON INVESTMENTS: 64,787. LOSS ON INTEREST RATE SWAP -7,050,089. TOTAL TO FORM 990, PART XI, LINE 5: -6,985,302.CHANGES IN NET ASSETS OR FUND BALANCES:
FORM 990, PART XII, LINE 2CTHE PROCESS FOR SELECTING THE AUDITOR FOR VAN ANDEL RESEARCH INSTITUTE'S FINANCIAL STATEMENTS DID NOT CHANGE DURING 2012.
PART III, LINE 3EFFECTIVE MARCH 12, 2012, VARI AND TGEN TERMINATED THEIR ALLIANCE AND AFFILIATION AGREEMENT AND TGEN CONVERTED FROM A MEMBER-BASED ARIZONA NOT-FOR-PROFIT CORPORATION TO A DIRECTOR-BASED ARIZONA NOT-FOR-PROFIT CORPORATION, WHEREBY VARI IS NO LONGER THE SOLE MEMBER OF TGEN. THE RESULTS OF OPERATIONS OF TGEN THROUGH THE EFFECTIVE TERMINATION DATE, ARE REFLECTED AS DISCONTINUED OPERATIONS WITHIN THE VAN ANDEL INSTITUTE AND AFFILIATES CONSOLIDATED AND CONSOLIDATING STATEMENTS OF ACTIVITIES AND CHANGES IN NET ASSETS (WHICH VARI IS PART OF). TGEN ASSETS, LIABILITIES AND NET ASSETS TRANSFERRED TOTALED $57,577,000, $21,348,000 AND $36,229,000, RESPECTIVELY. TGEN REVENUE AND SUPPORT EARNED BEFORE THE AGREEMENT TERMINATION, DURING FISCAL YEAR 2012 TOTALED $9,012,000. TGEN EXPENSES INCURRED BEFORE THE AGREEMENT TENNINATION, DURING FISCAL YEAR 2012 TOTALED $13,193,000. TGEN REVENUE AND SUPPORT EARNED FOR FISCAL YEAR ENDED NOVEMBER 30, 2011 TOTALED $54,670,000. TGEN EXPENSES INCURRED FOR FISCAL YEAR ENDED NOVEMBER 30, 2011 TOTALED $68,855,000.
FORM 990, PART III, LINES 4A-4CLINE 4A - PROGRAM SERVICE ACTIVITY #1 THE PROGRAM FOR BIOSPECIMEN SCIENCE HAS FOCUSED ON THE CHANGE IN BIOLOGICAL PARAMETERS AND QUALITY OF BIOSPECIMENS CAUSED BY COLLECTION, PROCESSING, AND STORAGE PROCEDURES. THE BIOREPOSITORY WITHIN THE PROGRAM FOR BIOSPECIMEN SCIENCE INCLUDES SCIENTIFIC EVALUATION ON THE PATTERNS OF DEGRADATION IN BIOSPECIMENS, DATABASE TRACKING AND MANAGEMENT OF BIOSPECIMEN INVENTORY; BIOSPECIMEN KIT DEVELOPMENT AND MANUFACTURING; SHIPPING AND TRACKING SERVICES; PROCUREMENT OF SURGICAL TISSUE AND BIOSPECIMENS FROM PATIENT POPULATIONS; QUALITY CONTROL ASSESSMENT OF OPERATIONS FOR THE COLLECTION AND BANKING OF BIOSPECIMENS; AND BIOSPECIMEN PROJECT MANAGEMENT. THE VARI BIOREPOSITORY CONTAINS APPROXIMATELY 10,000 FROZEN HUMAN TISSUES AND THEIR DERIVATIVES AND A PARAFFIN BLOCK ARCHIVE OF HUMAN DIAGNOSTIC TISSUES CURRENTLY EXCEEDING 900,000 BLOCKS. TISSUE ACQUISITION IS IN COLLABORATION WITH WEST MICHIGAN HOSPITALS, PROVIDING FRESH-FROZEN AND PARAFFIN-EMBEDDED SURGICAL TISSUES AND BLOOD FROM CONSENTING PATIENTS. THE BIOREPOSITORY IS DESIGNED TO PROVIDE HUMAN TUMORS TO INVESTIGATORS WITH IRB-APPROVED BASIC AND TRANSLATIONAL RESEARCH PROJECTS. ACCOMPLISHMENTS INCLUDE; MANAGING BIOREPOSITORY SERVICES FOR THE MULTIPLE MYELOMA RESEARCH FOUNDATION, THE NATIONAL CANCER INSTITUTE'S CANCER HUMAN BIOBANK (CAHUB), MULTIPLE BIOSPECIMEN ACQUISITION AND BIOREPOSITORY MANAGEMENT PROJECTS FOR VARI INVESTIGATORS, BIOREPOSITORY ACCREDITATION FROM THE COLLEGE OF AMERICAN PATHOLOGIST (CAP), AND A FOUNDING MEMBER OF THE GREAT LAKES BIOREPOSITORY RESEARCH NETWORK (GLBRN). LINE 4B - PROGRAM SERVICE ACTIVITY #2 SINCE DISCOVERING THE C-MET RECEPTOR AND ITS LIGAND HEPATOCYTE GROWTH FACTOR (HGF/SF) IN THE MID-1980S, THE LABORATORY OF MOLECULAR ONCOLOGY HAS FOCUSED ON INVESTIGATING THE PARAMOUNT ROLE THESE PROTEINS PLAY IN MALIGNANT PROGRESSION AND METASTASIS. MET IS OVEREXPRESSED IN MANY TYPES OF HUMAN CANCER, AND ITS EXPRESSION CORRELATES WITH AN AGGRESSIVE DISEASE AND POOR PROGNOSIS (HTTP://WWW.VAI.ORG/MET/). THE ABERRANT EXPRESSION OF MET IN MANY HUMAN TUMORS ALSO NECESSITATED THE DEVELOPMENT OF COMPANION DIAGNOSTICS TO IDENTIFY THOSE PATIENTS WHO COULD BENEFIT FROM MET TARGETED THERAPIES. AS PART OF THE ONGOING EFFORT TO FURTHER ENHANCE OUR UNDERSTANDING OF THE HGF/SF-MET SIGNALING PATHWAY, OUR LAB CURRENTLY FOCUSES ON THE PROJECTS DESCRIBED BELOW: - CONTINUING TO DEVELOP AND CHARACTERIZE NOVEL RESEARCH MODELS FOR A VARIETY OF HUMAN CANCERS (LIVER, BRAIN, BREAST, LUNG AND OTHERS) AND USING THEM FOR PRE-CLINICAL EVALUATION OF NEW C-MET INHIBITORS AS WELL AS OTHER THERAPEUTIC STRATEGIES - EVALUATING HGF AUTOCRINE AS A THERAPEUTIC MARKER PREDICTING SENSITIVITY TO C-MET INHIBITION USING VARIOUS GLIOBLASTOMA AND HEPATOCELLULAR CARCINOMA MODELS - STUDYING THE MECHANISMS RESPONSIBLE FOR PHENOTYPIC SWITCHING (E-MT/M-ET) AND EVALUATING THE ROLE OF CHROMOSOME INSTABILITY IN TUMOR PROGRESSION - INVESTIGATING THE ROLES OF MIG-6 AND THE MECHANISMS OF ITS ACTION IN CANCER DEVELOPMENT AND IN THE MAINTENANCE OF JOINT HOMEOSTASIS - PLANNING FURTHER IN VIVO DRUG COMBINATION STUDIES FOR DEVELOPING BETTER THERAPEUTIC STRATEGIES THAT WILL BE MORE EFFECTIVE THAN C-MET INHIBITOR AS A SINGLE AGENT IN TREATING MET-EXPRESSING TUMORS - INVESTIGATING HOW MET SIGNALING INTERACTS WITH THE ERBB FAMILY OF RECEPTORS IN THE PROGRESSION AND THERAPEUTIC RESISTANCE OF ERBB2-POSITIVE AND TRIPLE-NEGATIVE BREAST CANCERS - USING OUR UNIQUE HUMAN-HGF TRANSGENIC SCID MOUSE MODEL TO EXPLORE THE EFFECTIVENESS OF MET TARGETED THERAPY IN TREATING HUMAN CANCERS SUCH AS NON-SMALL CELL LUNG CANCER AND THE POTENTIAL MET DRUG RESISTANCE MECHANISM LINE 4C - PROGRAM SERVICE ACTIVITY #3 THE LABORATORY OF STRUCTURAL SCIENCES IS FOCUSED ON STUDYING THE STRUCTURES AND FUNCTIONS OF PROTEIN/ LIGAND COMPLEXES THAT PLAY KEY ROLES IN MAJOR HORMONE SIGNALING PATHWAYS. THE LABORATORY ALSO WORKS ON EXPLORING THE STRUCTURAL INFORMATION TO DEVELOP THERAPEUTIC AGENTS FOR TREATING HUMAN DISEASE, INCLUDING CANCER AND DIABETES. LAB STUDIES USE MULTIDISCIPLINARY APPROACHES, INCLUDING MOLECULAR AND CELLULAR BIOLOGY, BIOCHEMISTRY, ANIMAL PHYSIOLOGY, AND X-RAY CRYSTALLOGRAPHY. RESEARCH IN THIS GROUP CURRENTLY FOCUSES ON THREE AREAS: NUCLEAR HORMONE RECEPTORS, THE MET TYROSINE KINASE RECEPTOR, AND G PROTEIN-COUPLED RECEPTORS. THESE PROTEINS, BEYOND THEIR FUNDAMENTAL ROLES IN BIOLOGY, ARE IMPORTANT DRUG TARGETS. RECENT DISCOVERIES INCLUDE: THE CRYSTAL STRUCTURES OF EACH PEROXISOME PROLIFERATOR-ACTIVATED RECEPTORS (PPAR) LIGAND-BINDING DOMAIN (LBD) BOUND TO MANY DIVERSE LIGANDS IN ORDER TO UNDERSTAND THE MOLECULAR BASIS OF LIGAND-MEDIATED SIGNALING BY PPAR'S; THE CRYSTAL STRUCTURES OF THE RECEPTORS BOUND TO COACTIVATORS OR CO-REPRESSORS, WHICH PROVIDES A FRAMEWORK FOR UNDERSTANDING THE MECHANISMS OF PPAR AGONISTS AND ANTAGONIST AND THE RECRUITMENT OF COACTIVATORS AND CO-REPRESSORS; ANDROGEN RECEPTOR (AR) MUTATION IN PROSTATE CANCERS OFTEN RESULTS IN ENHANCED BINDING TO A PARTICULAR COACTIVATOR, SRC-3 (WHICH IS ALSO CALLED "AMPLIFIED IN BREAST CANCER1", OR AIB1); AND RETINOIC ACID IS A LOW-AFFINITY LIGAND FOR COUP-TF, WHICH IS ONE OF THE MOST CONSERVED NUCLEAR RECEPTORS AND HAS ESSENTIAL ROLES IN ANGIOGENESIS, HEART DEVELOPMENT, CNS ACTIVITY, AND METABOLIC HOMEOSTASIS. FOR THE MET TYROSINE KINASE RECEPTOR, THE LAB HAS DETERMINED THE CRYSTAL STRUCTURE OF THE C-MET LIGAND, HEPATOCYTE GROWTH FACTOR, NK1 AND NK2 VARIANTS, AND FOR G PROTEIN-COUPLED RECEPTORS (GPCRS) WE HAVE DETERMINED CRYSTAL STRUCTURES OF THE LIGAND BINDING DOMAIN OF THE PTH RECEPTOR AND THE CRF RECEPTOR, AND WE ARE DEVELOPING HORMONE ANALOGS FOR TREATING OSTEOPOROSIS, DEPRESSION, AND DIABETES. IN ADDITION, WE ARE DEVELOPING A MAMMALIAN OVEREXPRESSION SYSTEM AND PLAN TO USE IT TO EXPRESS FULL-LENGTH GPCRS FOR CRYSTALLIZATION AND STRUCTURAL STUDIES. THE LAB ALSO STUDIES THE PLANT HORMONE ABSCISIC ACID (ABA) SIGNALING PATHWAYS, WITH THEIR STRUCTURES OF ABA RECEPTORS BEING HIGHLIGHTED AS ONE OF TOP 10 SCIENTIFIC BREAKTHROUGHS BY SCIENCE IN 2009.
FORM 990, PART III, LINE 4DIN 2012, VARI RESEARCHERS FOUND WAYS TO POTENTIALLY DIAGNOSE AND FIGHT SEVERAL DIFFERENT TYPES OF CANCER AND NEURODEGENERATIVE DISEASES. BELOW ARE EXAMPLES OF SIGNIFICANT RESEARCH FINDINGS: - VARI RESEARCHERS PROVIDED A MORE COMPLETE UNDERSTANDING OF THE BIOLOGY OF TYPE 2 PAPILLARY RENAL CELL CARCINOMA (PRCC2), AN AGGRESSIVE TYPE OF KIDNEY CANCER WITH NO EFFECTIVE TREATMENT, WHICH WILL HELP DEVELOP EFFECTIVE TREATMENT STRATEGIES. - VARI RESEARCHERS INTEGRATED GENE EXPRESSION PROFILING AND RNAI SCREENING DATA TO IDENTIFY GENES INVOLVED IN THE DEVELOPMENT AND PROGRESSION OF CLEAR CELL RENAL CELL CARCINOMA (CCRCC), A SUB TYPE THAT ACCOUNTS FOR 75 PERCENT OF ALL KIDNEY CANCERS AND THAT, UNLIKE PRCC2, RESPONDS FAVORABLY TO DRUGS TARGETING VASCULAR ENDOTHELIAL GROWTH FACTOR. THE STUDY INDICATED THAT CELL-CYCLE-RELATED GENES, IN PARTICULAR PLK1, WERE ASSOCIATED WITH DISEASE AGGRESSIVENESS AND HIGHLIGHT PLK1 AS A PROMISING POTENTIAL THERAPEUTIC TARGET. - VARI RESEARCHERS DETERMINED THAT COMBINATION DRUG THERAPY MAY BE NEEDED TO COMBAT NON-SMALL CELL LUNG CANCER (NSCLC). THEY FOUND THAT PROTEIN SIGNALING PLAYS A CRITICAL ROLE IN TUMOR CELL DEVELOPMENT, ACTIVATING THE STAT3 GENE, AN OVERACTIVE GENE IN SEVERAL TYPES OF CANCER, IN SOME NSCLC CELL LINES. THIS TYPE OF PROTEIN-GENE SIGNALING PLAYS A CRUCIAL ROLE IN TUMOR CELL BEHAVIOR THAT MAY NOT BE IMPACTED BY DRUGS THAT SELECTIVELY TARGET THESE MUTATIONS. - AN INTERNATIONAL TEAM LED BY THE NCCS-VARI TRANSLATIONAL RESEARCH LABORATORY REPORTED THE FIRST COMPREHENSIVE GENOMIC STUDY OF BILE DUCT CANCER, DISCOVERING CRITICAL GENES RESPONSIBLE FOR THE ONSET OF THE DISEASE. IDENTIFYING NEW GENES FREQUENTLY MUTATED IN BILE DUCT CANCERS WILL LEAD TO A BETTER UNDERSTANDING OF HOW BILE DUCT CANCERS DEVELOP. - VARI BECAME PART OF A NATIONAL RESEARCH EFFORT TO HELP PATIENTS WITH MULTIPLE MYELOMA BY EXTRACTING AND STORING DNA AND RNA FROM TISSUE SAMPLES FOR NEXT-GENERATION SEQUENCING ANALYSIS. RESEARCHERS HOPE TO SHED NEW LIGHT ON THE RELATIONSHIP BETWEEN MOLECULAR VARIATION AND PATIENTS' RESPONSE OR RESISTANCE TO THERAPY. - VARI RESEARCHERS AND COLLEAGUES IN CHINA DEMONSTRATED THAT AN ELEVATED PERCENTAGE OF TH17 CELLS IN THE TUMOR MICROENVIRONMENT PLAY A CRUCIAL ROLE IN THE PRODUCTION AND ACCUMULATION OF A CELL CORRELATED TO SURVIVAL OF PATIENTS WITH NASOPHARYNGEAL CARCINOMA (NPC), A CANCER OF THE HEAD AND NECK. - RESEARCHERS FROM LUND UNIVERSITY IN SWEDEN, UNDER THE DIRECTION OF DR. PATRIK BRUNDIN, DIRECTOR OF THE VARI CENTER FOR NEURODEGENERATIVE SCIENCE ANNOUNCED A BREAKTHROUGH IN RESTORING NEURON FUNCTION TO PARTS OF THE BRAIN DAMAGED BY HUNTINGTON'S DISEASE BY SUCCESSFULLY TRANSPLANTING INDUCED PLURIPOTENT STEM (IPS) CELLS INTO ANIMAL MODELS. THEY ALSO PUBLISHED A STUDY DETAILING HOW PARKINSON'S DISEASE SPREADS THROUGH THE BRAIN. - VARI RESEARCHERS IDENTIFIED PLASMA-BASED MOLECULAR BIOMARKERS. MOLECULAR BIOMARKERS WOULD BE HIGHLY USEFUL CLINICAL TOOLS TO DETECT PARKINSON'S PRIOR TO THE DEVELOPMENT OF THE DISEASE'S MOTOR SYMPTOMS. - VARI SCIENTISTS MAPPING THE STRUCTURE OF THE RECEPTOR FOR ABSCISIC ACID (ABA), A PLANT HORMONE THAT CONTROLS GROWTH, DEVELOPMENT AND RESPONSES TO ENVIRONMENTAL STRESS, DISCOVERED THAT ABA REGULATES THE STRESS-RESPONSE PATHWAY BY AFFECTING AN ENZYME BELONGING TO THE PHOSPHATASE FAMILY.
FORM 990, PART X, LINE 33VARI NET ASSETS SHOULD BE CONSIDERED ON A CONSOLIDATED BASIS WITH VAN ANDEL INSTITUTE (VAI), VAN ANDEL EDUCATION INSTITUTE (VAEI), AND THE TRANSLATIONAL GENOMICS RESEARCH INSTITUTE (TGEN), RELATED PARTIES. ON A CONSOLIDATED BASIS, NET ASSETS ARE $1,024,607,000 PER AUDITED FINANCIAL STATEMENTS. THE NEGATIVE NET ASSET BALANCE AT VARI IS DUE TO VAI FUNDING EXPENSES ON A CASH BASIS AND THE UNREALIZED LOSS RECORDED IN ASSOCIATION WITH THE INTEREST RATE SWAP.
FORM 990, PART IX, COLUMN DFUNDRAISING EXPENSES AT VARI WERE INCURRED TO SUPPORT THE MISSION OF THE RESEARCH INSTITUTE THROUGH GRANT SOLICITATION AND EXTRAMURAL PROPOSAL PREPARATION.

Schedule R IRS990ScheduleR

Form990 Schedule R Part I Form990ScheduleRPartI (4 entries)

Address Line1AddressUS/AddressLine1CityAddressUS/CityStateAddressUS/StateZIP CodeAddressUS/ZIPCodeEINEINPrimary ActivitiesPrimaryActivitiesLegal Domicile StateLegalDomicileStateTotal IncomeTotalIncomeEOY AssetsEOYAssetsBusiness Name Line1DirectControllingEntityName/BusinessNameLine1
VAI INNOVATIONS LLC
333 BOSTWICK AVENUE NEGRAND RAPIDSMI495032518522000823LICENSING INTELLECTUAL PROPERTY OF VARIMI-55146110174VAN ANDEL RESEARCH INSTITUTE
VARI INTERNATIONAL
333 BOSTWICK AVENUE NEGRAND RAPIDSMI495032518262615936BIOMEDICAL RESEARCHMI147172379VAN ANDEL RESEARCH INSTITUTE
BOSTWICK EVENT MANAGEMENT
333 BOSTWICK AVENUE NEGRAND RAPIDSMI495032518522000823EVENT MANAGEMENTMI1659117458VAN ANDEL RESEARCH INSTITUTE
VARI-CLINXUS LLC
333 BOSTWICK AVENUE NEGRAND RAPIDSMI495032518274015168CLINICAL TRIALSMI-9541345834VAN ANDEL RESEARCH INSTITUTE

Form990 Schedule R Part II Form990ScheduleRPartII (5 entries)

Address Line1AddressUS/AddressLine1CityAddressUS/CityStateAddressUS/StateZIP CodeAddressUS/ZIPCodeEINEINPrimary ActivitiesPrimaryActivitiesLegal Domicile StateLegalDomicileStateExempt Code SectionExemptCodeSectionPublic Charity StatusPublicCharityStatusDirect Controlling Entity NADirectControllingEntityNAControlled OrgControlledOrgBusiness Name Line1DirectControllingEntityName/BusinessNameLine1
VAN ANDEL INSTITUTE
333 BOSTWICK AVENUE NEGRAND RAPIDSMI495032518522000820SUPPORTING ORGANIZATION FOR VARI AND VAEIMI501(C)(3)11CN/A0
VAN ANDEL EDUCATION INSTITUTE
333 BOSTWICK AVENUE NEGRAND RAPIDSMI495032518522000824OPERATING A SCHOOLMI501(C)(3)21VAN ANDEL INSTITUTE
VAN ANDEL INSTITUTE GRADUATE SCHOOL
333 BOSTWICK AVENUE NEGRAND RAPIDSME495032518203340886OPERATING A SCHOOLMI501(C)(3)21VAN ANDEL EDUCATION INSTITUTE
THE TRANSLATIONAL GENOMICS RESEARCH INSTITUTE
445 N 5TH STREET SUITE 600PHOENIXAZ85004753065445MEDICAL RESEARCHAZ501(C)(3)71VAN ANDEL RESEARCH INSTITUTE
TGEN RESEARCH INSTITUTE FOUNDATION
400 E VAN BUREN SUITE 850PHOENIXAZ85004331092191FUNDRAISINGAZ501(C)(3)71THE TRANSLATIONAL GENOMICS RESEARCH INSTITUTE

Form990 Schedule R Part IV Form990ScheduleRPartIV

Name Of Related Org NameOfRelatedOrg

FieldValueIRS element (for citing)
Business Name Line1TRANSMED SYSTEMS INCBusinessNameLine1

Address US AddressUS

FieldValueIRS element (for citing)
Address Line121170 CANYON OAK WAYAddressLine1
CityCUPERTINOCity
StateCAState
ZIP Code95014ZIPCode
FieldValueIRS element (for citing)
EIN272358859EIN
Primary ActivityPERSONALIZED MEDICINE SOFTWARE AND SERVICESPrimaryActivity
Legal Domicile StateDELegalDomicileState

Direct Controlling Entity Name DirectControllingEntityName

FieldValueIRS element (for citing)
Business Name Line1VAI INNOVATIONS LLCBusinessNameLine1
FieldValueIRS element (for citing)
Type Of EntityCTypeOfEntity
Share Of Total Income-1355136ShareOfTotalIncome
Share Of EOY Assets776718ShareOfEOYAssets
Percentage Ownership0.53370PercentageOwnership
FieldValueIRS element (for citing)
Receipt Of Int Ann Rents Royalties1ReceiptOfIntAnnRentsRoyalties
Gift Grant Or Cap Contr To Other Org1GiftGrantOrCapContrToOtherOrg
Gift Grant Or Cap Contr Fr Other Org1GiftGrantOrCapContrFrOtherOrg
Loans Or Guarantees To Other Org0LoansOrGuaranteesToOtherOrg
Loans Or Guarantees From Other Org1LoansOrGuaranteesFromOtherOrg
Sale Of Assets To Other Org0SaleOfAssetsToOtherOrg
Purchase Of Assets From Other Org0PurchaseOfAssetsFromOtherOrg
Exchange Of Assets0ExchangeOfAssets
Rental Of Facilities To Other Orgs0RentalOfFacilitiesToOtherOrgs
Rental Of Facilities Fr Other Orgs0RentalOfFacilitiesFrOtherOrgs
Perform Of Services For Other Orgs1PerformOfServicesForOtherOrgs
Perform Of Services By Other Orgs0PerformOfServicesByOtherOrgs
Sharing Of Facilities1SharingOfFacilities
Sharing Of Paid Employees1SharingOfPaidEmployees
Reimbursement Paid To Other Org1ReimbursementPaidToOtherOrg
Reimbursement Paid By Other Org1ReimbursementPaidByOtherOrg
Other Transfer To Other Org1OtherTransferToOtherOrg
Other Transfer From Other Org0OtherTransferFromOtherOrg

Transactions Related Orgs Table TransactionsRelatedOrgsTable (21 entries)

Transaction TypeTransactionTypeAmount InvolvedAmountInvolvedMethod Of Amt DeterminationMethodOfAmtDetermination
VAN ANDEL INSTITUTE
C47258660ACTUAL AMOUNT PAID
VAN ANDEL INSTITUTE
E52530000TOTAL RECORDED
VAN ANDEL INSTITUTE
M297514ALLOCATION BASED ON SQ. FOOTAGE
VAN ANDEL INSTITUTE
O122179ACTUAL AMOUNT PAID
VAN ANDEL INSTITUTE
N150926ALLOCATION BASED ON EFFORT
VAN ANDEL EDUCATION INSTITUTE
O113347ACTUAL AMOUNT PAID
VAN ANDEL EDUCATION INSTITUTE
P1185642ACTUAL AMOUNT RECEIVED
VAN ANDEL EDUCATION INSTITUTE
N64648APPORTIONED SALARY AND BENEFITS
VAN ANDEL EDUCATION INSTITUTE
N35015ALLOCATION BASED ON EFFORT
VAN ANDEL INSTITUTE GRADUATE SCHOOL
N16904ALLOCATION BASED ON EFFORT
VAN ANDEL INSTITUTE GRADUATE SCHOOL
M178508ALLOCATION BASED ON SQ. FOOTAGE
VAN ANDEL INSTITUTE GRADUATE SCHOOL
P421046ACTUAL AMOUNT RECEIVED
THE TRANSLATIONAL GENOMICS RESEARCH INSTITUTE
Q8000000ACTUAL AMOUNT PAID
THE TRANSLATIONAL GENOMIC RESEARCH INSTITUTE
N392174NET AMOUNT INVOICED
THE TRANSLATIONAL GENOMIC RESEARCH INSTITUTE
C767513ACTUAL GRANT TOTAL
THE TRANSLATIONAL GENOMIC RESEARCH INSTITUTE
K87486ACTUAL AMOUNT PAID
THE TRANSLATIONAL GENOMIC RESEARCH INSTITUTE
B25237ACCRUED PER CONTRACT
THE TRANSLATIONAL GENOMIC RESEARCH INSTITUTE
O136ACTUAL AMOUNT PAID
TRANSMED SYSTEMS INC
A291667ACCRUED PER CONTRACT
TRANSMED SYSTEMS INC
B712941ACTUAL AMOUNT PAID
VAN ANDEL INSTITUTE
P3518531ACTUAL AMOUNT PAID

Comments

Anonymous: no account or email. Up to 2,000 characters, at most one link. Comments are checked automatically; some wait for review.